🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣 We are excited to announce the 10th Heidelberg Myeloma Workshop   Join us on April 25–26, 2025, as international & local experts share the latest advancements in multiple myeloma research. #mmsm ✅ CME-certified 🔗 Speaker line-up & registration 👇🏼 myelomaworkshop.de

Congrats from your myeloma family 🙂 Mirco J. Friedrich

Long-term GMMG-RELAPSE in #MMsm, now officially in Blood Journal! Excellent 🇩🇪 trial that puts 🔩 in ⚰️ for 2nd ASCT unless no other options available. I'd missed these landmark analyses: no benefit even in pts who actually got 2nd ASCT or who had DOR > 4 yrs with first ASCT.

Myeloma Paper of the Day, April 18th, suggested by Robert Orlowski (Robert Z. Orlowski) MD Anderson Cancer Center Heidelberg Myeloma Marc S. Raab Leo Rasche oncodaily.com/science/myelom… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #MM #RRMM #MultipleMyeloma #Talquetamab

Time to progression after a frontline autologous transplant does not predict benefit from salvage autologous transplant. ow.ly/QCSm50VCOK6 #clinicaltrialsandobservations #lymphoidneoplasia #multiplemyeloma #transplantation

The optimal management of relapsed and/or refractory multiple myeloma in patients who have previously received frontline high-dose chemotherapy and autologous stem cell transplantation remains a subject of ongoing debate. ow.ly/W5iT50VCOEc #clinicaltrialsandobservations

Pre-meeting dinner with great collaborators and friends

Day 2 of the Heidelberg meeting more clinically focused today

Weekend highlight: GMMG Spring Meeting in Hamburg. Marc’s (Marc S. Raab) talk on upcoming clinical studies was, as always, spot on, clear, inspiring, & a solid look at what’s ahead. Plenty of work on the horizon, but honestly… I’m looking forward to it. #mmsm

Excited to share our work investigating the mutagenic impact of radiotherapy in hematological cancers out today in Blood Cancer Discovery!! 🎉 Another study born from amazing collaborations across Moffitt Cancer Center Heidelberg Myeloma University of Miami Memorial Sloan Kettering Cancer Center MSK Department of Medicine 💪 #lysm #wgs #RT #mmsm